144 related articles for article (PubMed ID: 21074011)
1. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Reid RL; Fortier MP; Smith L; Mirkin S; Grubb GS; Constantine GD
Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011
[TBL] [Abstract][Full Text] [Related]
2. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
[TBL] [Abstract][Full Text] [Related]
3. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
[TBL] [Abstract][Full Text] [Related]
7. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Freeman EW; Halbreich U; Grubb GS; Rapkin AJ; Skouby SO; Smith L; Mirkin S; Constantine GD
Contraception; 2012 May; 85(5):437-45. PubMed ID: 22152588
[TBL] [Abstract][Full Text] [Related]
8. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Anttila L; Kunz M; Marr J
Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
[TBL] [Abstract][Full Text] [Related]
9. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
Kashanian M; Shahpourian F; Zare O
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):47-51. PubMed ID: 20185226
[TBL] [Abstract][Full Text] [Related]
10. A look at the long-term safety of an extended-regimen OC.
Davis MG; Reape KZ; Hait H
J Fam Pract; 2010 May; 59(5):E3. PubMed ID: 20544040
[TBL] [Abstract][Full Text] [Related]
11. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Merz M; Kroll R; Lynen R; Bangerter K
Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical investigations of a variable-dose combined type oral contraceptive.
Briggs MH; Briggs M
Curr Med Res Opin; 1977; 5(3):213-6. PubMed ID: 162656
[TBL] [Abstract][Full Text] [Related]
13. Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose.
Kaneshiro B; Edelman A; Carlson NE; Nichols M; Jensen J
Contraception; 2012 Jul; 86(1):22-7. PubMed ID: 22176792
[TBL] [Abstract][Full Text] [Related]
14. Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.
Endrikat JS; Milchev NP; Kapamadzija A; Georgievska J; Gerlinger C; Schmidt W; Feroze S
Contraception; 2009 Jun; 79(6):428-32. PubMed ID: 19442777
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol).
Privrel T; Daubenfeld O
Br J Clin Pract; 1988 Jul; 42(7):292-8. PubMed ID: 3075505
[TBL] [Abstract][Full Text] [Related]
16. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
[TBL] [Abstract][Full Text] [Related]
17. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Kaunitz AM; Archer DF; Mishell DR; Foegh M
Am J Obstet Gynecol; 2015 Mar; 212(3):318.e1-8. PubMed ID: 25220709
[TBL] [Abstract][Full Text] [Related]
19. Continuous oral contraception. Strategies for managing breakthrough bleeding.
Freeman SB
Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
[No Abstract] [Full Text] [Related]
20. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.
Kroll R; Reape KZ; Margolis M
Contraception; 2010 Jan; 81(1):41-8. PubMed ID: 20004272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]